Read More Analyst Ratings Downgrades News Price Target New Street Research Downgrades Applied Materials to Neutral, Announces $140 Price Target By vishwanath@benzinga.com Today, 3:16 PM New Street Research analyst Pierre Ferragu downgrades Applied Materials (NASDAQ:AMAT) from Buy to Neutral and announces $140 price target. AMAT
Read More Analyst Ratings News Price Target HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $60 By Benzinga Newsdesk Today, 3:16 PM HC Wainwright & Co. analyst Joseph Pantginis maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and raises the price target from $54 to $60. CLDX
Read More Analyst Ratings Downgrades News Price Target Goldman Sachs Downgrades Essential Props Realty to Neutral, Lowers Price Target to $26 By Benzinga Newsdesk Today, 3:16 PM Goldman Sachs analyst Caitlin Burrows downgrades Essential Props Realty (NYSE:EPRT) from Buy to Neutral and lowers the price target from $31 to $26. EPRT
Read More Analyst Color Analyst Ratings Earnings News Price Target Reiteration 4 American Express Analysts Break Down Q2 Earnings By Nikhil Dayal Today, 3:16 PM Following American Express Co’s (NYSE: AXP) second-quarter earnings beat Friday, analysts from Barclays, Credit Suisse, RBC, and BMO provided key takeaways and revised forecasts. AXP